Key result
Ever use of oral corticosteroids was associated with a statistically significant increase in the odds of hip fracture compared to never use in older adults (adjusted OR 1.17).
Why the study?
Does oral corticosteroid use increase the risk of hip fracture in elderly individuals?
Case-Control (n=9,076)
Does oral corticosteroid use increase the risk of hip fracture in elderly individuals?
Odds Ratio: 1.17 (95% CI 1.08–1.28)
Oral corticosteroid use is associated with a small but statistically significant, dose-dependent increase in the risk of hip fracture among elderly individuals.
Oral corticosteroid use was associated with modestly higher hip fracture risk; leaves open whether findings warrant practice changes or generalize beyond Taiwan.
Aim. Little is known regarding the relationship between use of oral corticosteroids and hip fracture in the elderly in Taiwan. The aim of the study was to examine this issue. Methods. A retrospective population-based case-control study using the database of the Taiwan National Health Insurance Program (2000-2013) was conducted. We identified 4538 individuals aged ≥ 65 years with newly diagnosed hip fracture as the cases. We randomly selected 4538 individuals without hip fracture as the control subjects. The cases and the control subjects were matched with sex, age, comorbidities, and the year of index date. Individuals who never had any a prescription for oral corticosteroids were defined as never use. Individuals who ever had at least one prescription for oral corticosteroids were defined as ever use. The odds ratio (OR) and 95% confidence interval (CI) of hip fracture associated with oral corticosteroids use was estimated by a multivariable unconditional logistic regression analysis. Results. After adjustments for potential confounding factors, the multivariable logistic regression model showed that the adjusted OR of hip fracture was 1.17 for individuals with ever use of oral corticosteroids (95%CI 1.08, 1.28), compared to those with never use of oral corticosteroids. An sub-analysis showed that for every one-milligram increase in cumulative dose of oral corticosteroids, the adjusted OR of hip fracture was 1.01 (95% CI 1.01, 1.02). The adjusted ORs were 1.31 (95% CI 1.17, 1.47) for cumulative exposure to oral corticosteroids ≥ 3 months and 1.09 (95% CI 0.98, 1.20) for cumulative exposure < 3 months. Conclusions. We conclude that oral corticosteroids use is associated with a trivial but statistically significant increase in risk of hip fracture in Taiwan. Additionally, the results suggest that there are dose-response and duration-response effects of oral corticosteroids on the risk of hip fracture. The results confirm our understanding of oral corticosteroid-associated hip fracture in the elderly.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2017) conducted a case-control in Hip fracture (n=9,076). Oral corticosteroids vs. Never use of oral corticosteroids was evaluated on Hip fracture (OR 1.17, 95% CI 1.08, 1.28). Ever use of oral corticosteroids was associated with a statistically significant increase in the odds of hip fracture compared to never use in older adults (adjusted OR 1.17).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: